[go: up one dir, main page]

DK2897588T3 - Inhalerbart lægemiddel - Google Patents

Inhalerbart lægemiddel Download PDF

Info

Publication number
DK2897588T3
DK2897588T3 DK14809248.9T DK14809248T DK2897588T3 DK 2897588 T3 DK2897588 T3 DK 2897588T3 DK 14809248 T DK14809248 T DK 14809248T DK 2897588 T3 DK2897588 T3 DK 2897588T3
Authority
DK
Denmark
Prior art keywords
medicinal product
inhalable medicinal
inhalable
product
medicinal
Prior art date
Application number
DK14809248.9T
Other languages
English (en)
Inventor
Mukui Dalvi
Libo Wu
Original Assignee
Teva Branded Pharmaceutical Products R&D Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52014433&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2897588(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teva Branded Pharmaceutical Products R&D Inc filed Critical Teva Branded Pharmaceutical Products R&D Inc
Application granted granted Critical
Publication of DK2897588T3 publication Critical patent/DK2897588T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/468-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00Sprayers or atomisers specially adapted for therapeutic purposes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0001Details of inhalators; Constructional features thereof
    • A61M15/0021Mouthpieces therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/009Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK14809248.9T 2013-11-22 2014-11-21 Inhalerbart lægemiddel DK2897588T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361907782P 2013-11-22 2013-11-22
PCT/US2014/066872 WO2015077594A1 (en) 2013-11-22 2014-11-21 An inhalable medicament

Publications (1)

Publication Number Publication Date
DK2897588T3 true DK2897588T3 (da) 2019-08-12

Family

ID=52014433

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14809248.9T DK2897588T3 (da) 2013-11-22 2014-11-21 Inhalerbart lægemiddel

Country Status (18)

Country Link
US (1) US20160250197A1 (da)
EP (1) EP2897588B1 (da)
JP (1) JP2016539126A (da)
KR (1) KR20160101929A (da)
CN (1) CN104968328A (da)
AU (1) AU2014352813A1 (da)
CA (1) CA2930173A1 (da)
DK (1) DK2897588T3 (da)
EA (1) EA201691067A1 (da)
ES (1) ES2739393T3 (da)
HK (1) HK1211243A1 (da)
HU (1) HUE045868T2 (da)
IL (1) IL245760A0 (da)
MX (1) MX2016006377A (da)
PL (1) PL2897588T3 (da)
TR (1) TR201911194T4 (da)
WO (1) WO2015077594A1 (da)
ZA (1) ZA201603464B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20160101928A (ko) 2013-11-22 2016-08-26 테바 브랜디드 파마슈티컬 프로덕츠 알앤디, 인코포레이티드 흡입 약제
CA3036628C (en) * 2016-09-19 2021-11-16 Mexichem Fluor S.A. De C.V. Pharmaceutical compositions comprising tiotropium bromide monohydrate and 1,1-difluoroethane
US12220525B2 (en) * 2018-06-27 2025-02-11 Kindeva Drug Deliver L.P. Tiotropium formulation and inhaler

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9026191D0 (en) 1990-12-01 1991-01-16 Harris Pharma Ltd Breath actuated dispensing device
GB2264238A (en) 1992-05-29 1993-08-25 Norton Healthcare Ltd Medicament inhalor device
ZA939195B (en) * 1992-12-09 1995-06-08 Boehringer Ingelheim Pharma Stabilized medicinal aerosol solution formulations
SG52459A1 (en) * 1992-12-09 1998-09-28 Boehringer Ingelheim Pharma Stabilized medicinal aerosol solution formulations
US6553988B1 (en) 2000-06-09 2003-04-29 Norton Healthcare, Inc. Medicament dispensing device with a multimaterial diaphragm bounding a pneumatic force chamber
AU3297402A (en) * 2001-10-26 2003-10-30 Dey, L.P. An albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
JP2003221335A (ja) * 2001-10-26 2003-08-05 Dey Lp 慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、システム、キットおよび方法
JP2006510680A (ja) * 2002-12-16 2006-03-30 ベーリンガー インゲルハイム ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト チオトロピウムを含有するhfc溶液調合物
TWI359675B (en) * 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
US20070110676A1 (en) * 2005-11-17 2007-05-17 The Procter & Gamble Company Compositions useful for prevention and treatment of common cold and influenza-like symptoms
US8697719B2 (en) * 2009-08-07 2014-04-15 Generics [Uk] Limited Anhydrate of tiotropium bromide
US9061352B2 (en) * 2010-08-30 2015-06-23 Pulmatrix, Inc. Dry powder formulations and methods for treating pulmonary diseases
EP3470057B1 (en) * 2010-09-29 2021-11-03 Pulmatrix Operating Company, Inc. Cationic dry powders comprising magnesium salt
GB201200525D0 (en) * 2011-12-19 2012-02-29 Teva Branded Pharmaceutical Prod R & D Inc An inhalable medicament
KR20160101928A (ko) * 2013-11-22 2016-08-26 테바 브랜디드 파마슈티컬 프로덕츠 알앤디, 인코포레이티드 흡입 약제

Also Published As

Publication number Publication date
MX2016006377A (es) 2016-10-28
PL2897588T3 (pl) 2019-12-31
AU2014352813A1 (en) 2016-05-26
CN104968328A (zh) 2015-10-07
EA201691067A1 (ru) 2016-09-30
HUE045868T2 (hu) 2020-01-28
US20160250197A1 (en) 2016-09-01
IL245760A0 (en) 2016-07-31
ES2739393T3 (es) 2020-01-30
KR20160101929A (ko) 2016-08-26
CA2930173A1 (en) 2015-05-28
HK1211243A1 (en) 2016-05-20
EP2897588B1 (en) 2019-07-17
WO2015077594A1 (en) 2015-05-28
TR201911194T4 (tr) 2019-08-21
ZA201603464B (en) 2017-09-27
JP2016539126A (ja) 2016-12-15
EP2897588A1 (en) 2015-07-29

Similar Documents

Publication Publication Date Title
BR112016009485A2 (pt) Inalador de medicamento
DK3030262T3 (da) Kombineret farmaceutisk sammensætning
DK3062849T3 (da) Medikamentadministrationsanordning
DK2983721T4 (da) Terapeutiske indgivelsesvesikler
DK2970389T3 (da) Farmaceutiske forbindelser
DK3038674T3 (da) Medikamentafgivelsesindretning
DK3079655T3 (da) Inhalerbare lægemidler
UA29750S (uk) Інгалятор
HUE049248T2 (hu) Inhalátor
HUE053417T2 (hu) Inhalátor
EP2964774A4 (en) PTD SMAD7 THERAPEUTICS
DK3079667T3 (da) Farmaceutiske doseringsformer
PT3035887T (pt) Inalador
DK3003401T3 (da) Farmaceutisk præparat
HUE036748T2 (hu) Inhalálható gyógyszer
DK2897588T3 (da) Inhalerbart lægemiddel
DK2983747T3 (da) Lægemiddelindgivelsesindretning
BR302012003979S1 (pt) Configuração aplicada em fármaco
UA29751S (uk) Інгалятор
UA28338S (uk) Медичний пристрій-шприц
UA28339S (uk) Медичний пристрій-шприц
UA28330S (uk) Капсула для лікарського засобу
UA28963S (uk) Пляшечка на ліки
UA28964S (uk) Пляшечка на ліки
UA26185S (uk) Пляшечка на ліки